Scientists just flipped the script on cancer’s defenses! Some tumors hoard a mutant protein, and now researchers have made a drug that uses this overload against the cancer. The new two-part drug latches onto the mutant protein and drags in a cell-killing enzyme, hitting cancer cells way harder than healthy ones. Early tests show it’s especially effective for cancers with the Y220C mutation. This could mean smarter, more targeted treatments are on the way! #Health #BodyHealth #CancerResearch